PUNE, India, January 25, 2017 /PRNewswire/ --
According to a new market research report "Pharmaceutical Membrane Filtration Market by Product (MCE, Coated Cellulose Acetate, Nylon, PVDF Membrane), Technique (Microfiltration, Ultra Filtration, Nanofiltration), Application (Final Product, Raw Material) - Global Forecast to 2021" published by MarketsandMarkets, the market is expected to reach USD 6.20 Billion by 2021 from USD 3.55 Billion in 2016, at a CAGR of 11.8% from 2016 to 2021.
Browse 65 market data Tables and 35 Figures spread through 139 Pages and in-depth TOC on "Pharmaceutical Membrane Filtration Market"
Early buyers will receive 10% customization on this report.
This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global Pharmaceutical Membrane Filtration Market along with the estimates and forecasts of the revenue and market share analysis. Factors such as growth in the biopharmaceutical industry and rapid growth in generic drug production are driving the growth of this market. In this report, the global Pharmaceutical Membrane Filtration Market has been segmented based on product, technique, application, and region. On the basis of product, the market has been segmented into MCE membrane filters, coated cellulose acetate membrane filters, nylon membrane filters, PTFE membrane filters, PVDF membrane filters, and other membrane filters. The MCE membrane filters segment is expected to account for the largest share of the market in 2016. The high growth in this segment is primarily attributed to the high adoption rate of membrane filtration products.
Based on technique, the Pharmaceutical Membrane Filtration Market has been segmented into microfiltration, ultrafiltration, crossfiltration, nanofiltration, reverse osmosis, and ion exchange. The microfiltration segment is projected to witness the highest CAGR during the forecast period. This growth can be attributed to the high production of pharmaceutical products and drugs.
Based on application, the global Pharmaceutical Membrane Filtration Market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing segment is further divided into active pharmaceutical ingredient (API) filtration, sterile filtration, protein purification, vaccines & antibody processing, formulation & filling solutions, and viral clearance. The final product processing segment is projected to witness the highest growth rate during the forecast period.
Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=255408031
Based on region, the global Pharmaceutical Membrane Filtration Market is segmented into North America, Asia, Europe, and the Rest of the World (RoW). North America is expected to account for the largest share of the market in 2016. Growth in this regional segment is driven by factors such as increase in generic drug production and increasing incidence of airborne diseases.
Key players in the Pharmaceutical Membrane Filtration Market include Merck KGaA (Germany), General Healthcare Company (U.K.), Pall Corporation (U.S.), Sartorius Stedim Biotech Group (France), Alfa Laval (Sweden), Graver Technologies, LLC (U.S.), Koch Membrane Systems Inc. (U.S.), GEA Group (Germany), and Novasep (U.S.).
Browse Related Reports:
Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), by Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Accessories) & by End User - Global Forecast to 2021
Pharmaceutical Filtration Market by Product (Membrane Filters, Single-use systems), Techniques (Ultrafiltration, Cross Flow Filtration), Applications, Scale of Operations, Geography (North America, Europe) - Global Forecast to 2020
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Email: [email protected]
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets